LPL Financial’s Alder Biopharmaceuticals ALDR Stock Holding History

LPL Financial’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,548	Closed	-$406K	–	3488
2019 Q3	$406K	Buy	21,548 +1,000	+5%	+$11.4K	﹤0.01%	2435
2019 Q2	$242K	Buy	20,548 +373	+2%	+$4.52K	﹤0.01%	2882
2019 Q1	$275K	Buy	20,175 +2,000	+11%	+$25.9K	﹤0.01%	2719
2018 Q4	$186K	Buy	18,175 +5,500	+43%	+$70.4K	﹤0.01%	2832
2018 Q3	$211K	Sell	12,675 -3,617	-22%	-$65.4K	﹤0.01%	2966
2018 Q2	$257K	Buy	16,292 +4,020	+33%	+$61.1K	﹤0.01%	2794
2018 Q1	$156K	Buy	+12,272	New	+$178K	﹤0.01%	3013

LPL Financial's ALDR Position: Q4 2019 in Review

LPL Financial sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 21,548 shares — an estimated $406K sold.

LPL Financial first reported a position in ALDR in Q1 2018 and held it in 7 quarters. The position peaked at $406K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

LPL Financial reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
LPL Financial sold 21,548 Alder Biopharmaceuticals shares in Q4 2019, an estimated $406K.
LPL Financial first reported a position in Alder Biopharmaceuticals in Q1 2018 and held it in 7 quarters.
LPL Financial's Alder Biopharmaceuticals position peaked at $406K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on LPL Financial's 13F filing for Q4 2019, filed 14 Feb 2020.